Loading...
Quality Care 2018-03-08T16:47:09+00:00

HIGHER QUALITY DATA
HELPING YOU MEET HIGHER STANDARDS

Precision Medicine is only as effective as the technology, treatments and associated data used to advance it. At the heart of this data is the need to uphold strict standards for testing and data collection. We work with professionals across the healthcare industry, including laboratories, clinicians and even the government, to help provide quality data reporting. Laboratories and clinicians participating in the N1 Registry™ have agreed to provide quality testing and treatments.

WE ARE A QCDR –
BUT WHAT DOES THAT MEAN?

The CureOne™ N1 Registry™ is the only registry of its kind that has been designated by the Centers for Medicare Services (CMS) as a Qualified Clinical Data Registry (QCDR). This status allows CureOne to report quality improvement activities of physicians in providing molecular testing and targeted therapy for their patients. We introduced six Effective Care metrics and five Outcome Measures that were accepted by CMS. Through this status, CureOne continues to demonstrate its commitment to upholding quality data standards.

“Breathtaking technological advances over the last few years have fueled the use of next generation sequencing (NGS) in the clinic. Understanding the clinical utility of this important tool is now critical. CureOne … will provide an open repository of data and a deeper understanding of clinical and therapeutic correlates of patients treated after their tumors have undergone NGS.”

CureOne clinical leadershipRAZELLE KURZROCK, MD
Senior Deputy Director, Clinical Science, UC San Diego

WHY WORK WITH THE CUREONE QCDR

When a clinician participating in the N1 Registry orders molecular testing for patients with advanced lung cancer or melanoma, CureOne can report on the established biomarker quality metrics to the CMS Medicare Merit Based Incentive Payment System (MIPS). As a QCDR, CureOne facilitates the demonstration of evidence-based medicine through the utilization of guideline supported molecular testing.

BENEFITS TO CLINICS

Get molecular testing for your patients that isn’t accessible through other means.
Show Medicare that you are practicing quality medicine.
Help us build a national database of genetic information that will advance the precision of oncology treatments.
We’ll pay you for it.
GET STARTED